Cargando…
Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies
Regulatory T cells (Tregs) are responsible for maintaining immune homeostasis by controlling immune responses. They can be characterized by concomitant expression of FoxP3, CD25 and inhibitory receptors such as PD-1 and CTLA-4. Tregs are key players in preventing autoimmunity and are dysregulated in...
Autores principales: | Maharaj, Kamira, Uriepero, Angimar, Sahakian, Eva, Pinilla-Ibarz, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376239/ https://www.ncbi.nlm.nih.gov/pubmed/35979372 http://dx.doi.org/10.3389/fimmu.2022.943354 |
Ejemplares similares
-
HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model
por: Maharaj, Kamira, et al.
Publicado: (2020) -
Regulation of Treg Cell Metabolism and Function in Non-Lymphoid Tissues
por: Yang, Kai
Publicado: (2022) -
The role of Th17 cells in chronic lymphocytic leukemia: friend or foe?
por: Gamal, Wael, et al.
Publicado: (2022) -
Stability and Maintenance of Foxp3(+) Treg Cells in Non-lymphoid Microenvironments
por: Korn, Thomas, et al.
Publicado: (2019) -
Ibrutinib: an evidence-based review of its potential in the treatment of advanced chronic lymphocytic leukemia
por: Chavez, Julio C, et al.
Publicado: (2013)